TP53 and pancreatic adenocarcinoma: Depending on multi-omics data for TCGA-PAAD cohort, the integrative mutational landscape of pharmacogenomics-classified subtype agreed with published researches that the most frequent mutated genes are KRAS, TP53, CDKN2A, and SMAD4, the four driven factors generally recognized.